Similar articles

• The Occlutech Figulla PFO and ASD occluder: a new nitinol wire mesh device for closure of atrial septal defects.

  Krizanic F, Sievert H, Pfeiffer D, Konorza T, Ferrari M, Hijazi Z, Jung C, Lauten A, Figulla HR. Krizanic F, et al. J Invasive Cardiol. 2010 Apr;22(4):182-7. J Invasive Cardiol. 2010. PMID: 20351390
• Percutaneous closure of atrial septal defects: immediate and mid-term results.

  Dardas PS, Ninios VN, Mezilis NE, Tsikaderis DD, Thanopoulos VD. Dardas PS, et al. Hellenic J Cardiol. 2010 Mar-Apr;51(2):104-12. Hellenic J Cardiol. 2010. PMID: 20378511
• Risk of cerebral embolism after interventional closure of symptomatic patent foramen ovale or atrial septal defect: a diffusion-weighted MRI and neuron-specific enolase-based study.

  Oktay Tureli H, Ungan I, Tureli D, Demir B, Pirhan O, Bayrak HI, Caglar IM, Karakaya O, Inci E. Oktay Tureli H, et al. J Invasive Cardiol. 2013 Oct;25(10):519-24. J Invasive Cardiol. 2013. PMID: 24088426
• Echocardiographic assessment of percutaneous patent foramen ovale and atrial septal defect closure complications.

  Yared K, Baggish AL, Solis J, Durst R, Passeri JJ, Palacios IF, Picard MH. Yared K, et al. Circ Cardiovasc Imaging. 2009 Mar;2(2):141-9. doi: 10.1161/CIRCIMAGING.108.832436. Circ Cardiovasc Imaging. 2009. PMID: 19808580 Review. No abstract available.
• Short and long term complications of device closure of atrial septal defect and patent foramen ovale: meta-analysis of 28,142 patients from 203 studies.

  Abaci A, Unlu S, Alsancak Y, Kaya U, Sezenoz B. Abaci A, et al. Catheter Cardiovasc Interv. 2013 Dec 1;82(7):1123-38. doi: 10.1002/ccd.24875. Epub 2013 Aug 31. Catheter Cardiovasc Interv. 2013. PMID: 23412921 Review.